Moderna has submitted a regulatory application to the FDA for mRNA-1273.815, an updated monovalent COVID-19 vaccine specifically targeting XBB descendant lineage viruses.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.